Maria Tsokos

Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1998, The Journal of clinical endocrinology and metabolism.

Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.

G. Chrousos, S. Bornstein, D. Torpy, 1998, Endocrinology.

Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.

N. Mitsiades, V. Poulaki, M. Tsokos, 1998, The American journal of pathology.

Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.

N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, 1999, The Journal of clinical endocrinology and metabolism.

Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues

M. Raffeld, E. Perlman, M. Tsokos, 2000, Modern Pathology.

A pleiomorphic GH pituitary adenoma from a Carney complex patient displays universal allelic loss at the protein kinase A regulatory subunit 1A (PRKARIA) locus

I. Bossis, C. Stratakis, D. Batista, 2004, Journal of Medical Genetics.